Licensing of antirheumatic drugs: are the EMA and FDA on the same page?

Joint Bone Spine. 2013 Mar;80(2):121-3. doi: 10.1016/j.jbspin.2012.09.024. Epub 2012 Nov 7.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Europe
  • Humans
  • Licensure*
  • Rheumatic Diseases / drug therapy*
  • United States
  • United States Food and Drug Administration*

Substances

  • Antirheumatic Agents